Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre-randomization phase of the Polyneuropathy And Treatment with Hizentra study Article
Overview
publication date
- January 1, 2019
published in
Identity
Scopus Document Identifier
- 85062531892
Digital Object Identifier (DOI)
- 10.1111/jns.12303